Technology in Cancer Research and Treatment This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

miRNA-130a-3p/CPEB4 Axis Modulates Glioblastoma Growth and Progression
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231218218. doi: 10.1177/15330338231218218.ABSTRACTGlioblastoma is the most frequent form of malignant brain tumor. Cytoplasmic polyadenylation element binding protein 4 (CPEB4) is overexpressed and involved in the tumorigenesis and metastasis of glioblastoma. miR-130a-3p has been revealed to be aberrantly expressed in tumors and has aroused wide attention. In present study, we would like to investigate the effect and potential mechanism of miR-130a-3p on the proliferation and migration in glioblastoma. The relative expression levels of miR-130a-3p and CPEB4 in glioblastoma ...
Source: Technology in Cancer Research and Treatment - December 22, 2023 Category: Cancer & Oncology Authors: Hongchao Liu Zhihao Wei Kangke Shi Yu Zhang Jiaqiong Li Source Type: research

Commentary: Nanoparticle-Based Chemotherapy Delivery and Potential Health Risks: Prospects for Effective Clinical Translation
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231220171. doi: 10.1177/15330338231220171.ABSTRACTWith recent advancements, chemotherapy is one of the most prevalent regimens for cancer treatment. However, the heterogeneity of tumor biology and healthy cell-damaging potential of chemotherapy remain challenges. As a solution, nanoparticle-based delivery is advancing. Besides its promising potential, effective clinical translation and commercialization of nanoparticle-based chemotherapy should get attention to ensure the absence of potential health risks. Specifically, the permeability potential of nanoparticles across bio...
Source: Technology in Cancer Research and Treatment - December 22, 2023 Category: Cancer & Oncology Authors: Desta Assefa Tsegaye Melaku Sintayehu Alemu Source Type: research

miRNA-130a-3p/CPEB4 Axis Modulates Glioblastoma Growth and Progression
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231218218. doi: 10.1177/15330338231218218.ABSTRACTGlioblastoma is the most frequent form of malignant brain tumor. Cytoplasmic polyadenylation element binding protein 4 (CPEB4) is overexpressed and involved in the tumorigenesis and metastasis of glioblastoma. miR-130a-3p has been revealed to be aberrantly expressed in tumors and has aroused wide attention. In present study, we would like to investigate the effect and potential mechanism of miR-130a-3p on the proliferation and migration in glioblastoma. The relative expression levels of miR-130a-3p and CPEB4 in glioblastoma ...
Source: Technology in Cancer Research and Treatment - December 22, 2023 Category: Cancer & Oncology Authors: Hongchao Liu Zhihao Wei Kangke Shi Yu Zhang Jiaqiong Li Source Type: research

Commentary: Nanoparticle-Based Chemotherapy Delivery and Potential Health Risks: Prospects for Effective Clinical Translation
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231220171. doi: 10.1177/15330338231220171.ABSTRACTWith recent advancements, chemotherapy is one of the most prevalent regimens for cancer treatment. However, the heterogeneity of tumor biology and healthy cell-damaging potential of chemotherapy remain challenges. As a solution, nanoparticle-based delivery is advancing. Besides its promising potential, effective clinical translation and commercialization of nanoparticle-based chemotherapy should get attention to ensure the absence of potential health risks. Specifically, the permeability potential of nanoparticles across bio...
Source: Technology in Cancer Research and Treatment - December 22, 2023 Category: Cancer & Oncology Authors: Desta Assefa Tsegaye Melaku Sintayehu Alemu Source Type: research

miRNA-130a-3p/CPEB4 Axis Modulates Glioblastoma Growth and Progression
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231218218. doi: 10.1177/15330338231218218.ABSTRACTGlioblastoma is the most frequent form of malignant brain tumor. Cytoplasmic polyadenylation element binding protein 4 (CPEB4) is overexpressed and involved in the tumorigenesis and metastasis of glioblastoma. miR-130a-3p has been revealed to be aberrantly expressed in tumors and has aroused wide attention. In present study, we would like to investigate the effect and potential mechanism of miR-130a-3p on the proliferation and migration in glioblastoma. The relative expression levels of miR-130a-3p and CPEB4 in glioblastoma ...
Source: Technology in Cancer Research and Treatment - December 22, 2023 Category: Cancer & Oncology Authors: Hongchao Liu Zhihao Wei Kangke Shi Yu Zhang Jiaqiong Li Source Type: research

Commentary: Nanoparticle-Based Chemotherapy Delivery and Potential Health Risks: Prospects for Effective Clinical Translation
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231220171. doi: 10.1177/15330338231220171.ABSTRACTWith recent advancements, chemotherapy is one of the most prevalent regimens for cancer treatment. However, the heterogeneity of tumor biology and healthy cell-damaging potential of chemotherapy remain challenges. As a solution, nanoparticle-based delivery is advancing. Besides its promising potential, effective clinical translation and commercialization of nanoparticle-based chemotherapy should get attention to ensure the absence of potential health risks. Specifically, the permeability potential of nanoparticles across bio...
Source: Technology in Cancer Research and Treatment - December 22, 2023 Category: Cancer & Oncology Authors: Desta Assefa Tsegaye Melaku Sintayehu Alemu Source Type: research

miRNA-130a-3p/CPEB4 Axis Modulates Glioblastoma Growth and Progression
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231218218. doi: 10.1177/15330338231218218.ABSTRACTGlioblastoma is the most frequent form of malignant brain tumor. Cytoplasmic polyadenylation element binding protein 4 (CPEB4) is overexpressed and involved in the tumorigenesis and metastasis of glioblastoma. miR-130a-3p has been revealed to be aberrantly expressed in tumors and has aroused wide attention. In present study, we would like to investigate the effect and potential mechanism of miR-130a-3p on the proliferation and migration in glioblastoma. The relative expression levels of miR-130a-3p and CPEB4 in glioblastoma ...
Source: Technology in Cancer Research and Treatment - December 22, 2023 Category: Cancer & Oncology Authors: Hongchao Liu Zhihao Wei Kangke Shi Yu Zhang Jiaqiong Li Source Type: research

Commentary: Nanoparticle-Based Chemotherapy Delivery and Potential Health Risks: Prospects for Effective Clinical Translation
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231220171. doi: 10.1177/15330338231220171.ABSTRACTWith recent advancements, chemotherapy is one of the most prevalent regimens for cancer treatment. However, the heterogeneity of tumor biology and healthy cell-damaging potential of chemotherapy remain challenges. As a solution, nanoparticle-based delivery is advancing. Besides its promising potential, effective clinical translation and commercialization of nanoparticle-based chemotherapy should get attention to ensure the absence of potential health risks. Specifically, the permeability potential of nanoparticles across bio...
Source: Technology in Cancer Research and Treatment - December 22, 2023 Category: Cancer & Oncology Authors: Desta Assefa Tsegaye Melaku Sintayehu Alemu Source Type: research

miRNA-130a-3p/CPEB4 Axis Modulates Glioblastoma Growth and Progression
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231218218. doi: 10.1177/15330338231218218.ABSTRACTGlioblastoma is the most frequent form of malignant brain tumor. Cytoplasmic polyadenylation element binding protein 4 (CPEB4) is overexpressed and involved in the tumorigenesis and metastasis of glioblastoma. miR-130a-3p has been revealed to be aberrantly expressed in tumors and has aroused wide attention. In present study, we would like to investigate the effect and potential mechanism of miR-130a-3p on the proliferation and migration in glioblastoma. The relative expression levels of miR-130a-3p and CPEB4 in glioblastoma ...
Source: Technology in Cancer Research and Treatment - December 22, 2023 Category: Cancer & Oncology Authors: Hongchao Liu Zhihao Wei Kangke Shi Yu Zhang Jiaqiong Li Source Type: research

Commentary: Nanoparticle-Based Chemotherapy Delivery and Potential Health Risks: Prospects for Effective Clinical Translation
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231220171. doi: 10.1177/15330338231220171.ABSTRACTWith recent advancements, chemotherapy is one of the most prevalent regimens for cancer treatment. However, the heterogeneity of tumor biology and healthy cell-damaging potential of chemotherapy remain challenges. As a solution, nanoparticle-based delivery is advancing. Besides its promising potential, effective clinical translation and commercialization of nanoparticle-based chemotherapy should get attention to ensure the absence of potential health risks. Specifically, the permeability potential of nanoparticles across bio...
Source: Technology in Cancer Research and Treatment - December 22, 2023 Category: Cancer & Oncology Authors: Desta Assefa Tsegaye Melaku Sintayehu Alemu Source Type: research

miRNA-130a-3p/CPEB4 Axis Modulates Glioblastoma Growth and Progression
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231218218. doi: 10.1177/15330338231218218.ABSTRACTGlioblastoma is the most frequent form of malignant brain tumor. Cytoplasmic polyadenylation element binding protein 4 (CPEB4) is overexpressed and involved in the tumorigenesis and metastasis of glioblastoma. miR-130a-3p has been revealed to be aberrantly expressed in tumors and has aroused wide attention. In present study, we would like to investigate the effect and potential mechanism of miR-130a-3p on the proliferation and migration in glioblastoma. The relative expression levels of miR-130a-3p and CPEB4 in glioblastoma ...
Source: Technology in Cancer Research and Treatment - December 22, 2023 Category: Cancer & Oncology Authors: Hongchao Liu Zhihao Wei Kangke Shi Yu Zhang Jiaqiong Li Source Type: research

Commentary: Nanoparticle-Based Chemotherapy Delivery and Potential Health Risks: Prospects for Effective Clinical Translation
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231220171. doi: 10.1177/15330338231220171.ABSTRACTWith recent advancements, chemotherapy is one of the most prevalent regimens for cancer treatment. However, the heterogeneity of tumor biology and healthy cell-damaging potential of chemotherapy remain challenges. As a solution, nanoparticle-based delivery is advancing. Besides its promising potential, effective clinical translation and commercialization of nanoparticle-based chemotherapy should get attention to ensure the absence of potential health risks. Specifically, the permeability potential of nanoparticles across bio...
Source: Technology in Cancer Research and Treatment - December 22, 2023 Category: Cancer & Oncology Authors: Desta Assefa Tsegaye Melaku Sintayehu Alemu Source Type: research

miRNA-130a-3p/CPEB4 Axis Modulates Glioblastoma Growth and Progression
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231218218. doi: 10.1177/15330338231218218.ABSTRACTGlioblastoma is the most frequent form of malignant brain tumor. Cytoplasmic polyadenylation element binding protein 4 (CPEB4) is overexpressed and involved in the tumorigenesis and metastasis of glioblastoma. miR-130a-3p has been revealed to be aberrantly expressed in tumors and has aroused wide attention. In present study, we would like to investigate the effect and potential mechanism of miR-130a-3p on the proliferation and migration in glioblastoma. The relative expression levels of miR-130a-3p and CPEB4 in glioblastoma ...
Source: Technology in Cancer Research and Treatment - December 22, 2023 Category: Cancer & Oncology Authors: Hongchao Liu Zhihao Wei Kangke Shi Yu Zhang Jiaqiong Li Source Type: research

Commentary: Nanoparticle-Based Chemotherapy Delivery and Potential Health Risks: Prospects for Effective Clinical Translation
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231220171. doi: 10.1177/15330338231220171.ABSTRACTWith recent advancements, chemotherapy is one of the most prevalent regimens for cancer treatment. However, the heterogeneity of tumor biology and healthy cell-damaging potential of chemotherapy remain challenges. As a solution, nanoparticle-based delivery is advancing. Besides its promising potential, effective clinical translation and commercialization of nanoparticle-based chemotherapy should get attention to ensure the absence of potential health risks. Specifically, the permeability potential of nanoparticles across bio...
Source: Technology in Cancer Research and Treatment - December 22, 2023 Category: Cancer & Oncology Authors: Desta Assefa Tsegaye Melaku Sintayehu Alemu Source Type: research

miRNA-130a-3p/CPEB4 Axis Modulates Glioblastoma Growth and Progression
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231218218. doi: 10.1177/15330338231218218.ABSTRACTGlioblastoma is the most frequent form of malignant brain tumor. Cytoplasmic polyadenylation element binding protein 4 (CPEB4) is overexpressed and involved in the tumorigenesis and metastasis of glioblastoma. miR-130a-3p has been revealed to be aberrantly expressed in tumors and has aroused wide attention. In present study, we would like to investigate the effect and potential mechanism of miR-130a-3p on the proliferation and migration in glioblastoma. The relative expression levels of miR-130a-3p and CPEB4 in glioblastoma ...
Source: Technology in Cancer Research and Treatment - December 22, 2023 Category: Cancer & Oncology Authors: Hongchao Liu Zhihao Wei Kangke Shi Yu Zhang Jiaqiong Li Source Type: research